Pasar al contenido principal

PAPEL DE POBLACIONES MIELOIDES DE LA MEDULA OSEA EN LA DISFUNCION DE CELULAS INMUNITARIAS Y PROGENITORES HEMATOPOYETICOS INDUCIDA POR LA OBESIDAD

PID2024-159862OB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para la Investigación y el Desarrollo Experimental
Subprograma Subprograma Estatal de Generación de Conocimiento Científico-Técnico y Desarrollo Experimental
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2024
Plan Estatal 2024-2027 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSITAT POMPEU FABRA CCT

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Poorly perfused tumor regions harbor T cells with a glucose-dependent effector phenotype

  • Riera-Borrull, Marta
  • Cerdán Porqueras, Víctor
  • Tejedor Vaquero, Sonia, 1988-
  • Tomaselli González, Claudia
  • Guzmán, Mauricio
  • Martinuzzi, Donata
  • Ceacero-Heras, Diego
  • Cerutti, Andrea, 1965-
  • Aramburu, José (Aramburu Beltrán)
  • López Rodríguez, M. Cristina
Data de publicació electrònica: 27-05-2026, Effector T lymphocytes are avid nutrient consumers, but can function in nutrient-poor tumor microenvironments. Availability of key nutrients such as glucose inside the tumor is not homogeneous, and how tumor-infiltrating T lymphocytes (TILs) differ between regions with better and poorer blood perfusion is not well known. Here we show that in vitro-stimulated TILs can induce substantial production of hallmark glucose-dependent cytokines under glucose concentrations 20 times lower than in blood. In vivo, effector TILs in tumor regions with poor access to blood show comparable capacity for inducing IFNγ and granzyme B to TILs with fuller accessibility; exhibit an enhanced type I IFN response supported by local myeloid cells; and unexpectedly, have reduced expression of immune checkpoint and Treg-associated markers. TILs with poor blood accessibility also have lower biosynthetic activity than highly blood-accessible TILs, yet both compartments depend fundamentally on glucose for ATP production. Thus, effector T lymphocytes in poorly perfused tumor regions can maintain specific glucose-dependent responses, and might be partially protected from inhibitory and exhausting pressure from the tumor microenvironment., We would like to thank Òscar Fornas, Nico Baeza, Alexandre Bote, Eva Julià, and Erica Ramírez of the Universitat Pompeu Fabra and Center for Genomic Regulation (UPF/CRG) Flow Cytometry Unit for excellent guidance with flow cytometry. We also thank Jochen Hecht, Irene Navarrete (CRG Genomics Unit) and the CRG Genomics Unit for advice with and performing the RNA-sequencing; and Julia Ponomarenko and Sarah Bonnin (CRG Bioinformatics Unit) for bioinformatics analysis of RNA-sequencing data. CLR and JA were funded by: grants RTI2018-095902-B-I00, PID2021-128721OB-I00, and PID2024-159862OB-I00, from Agencia Estatal de Investigación MICIU/AEI/ 10.13039/501100011033 and the European Fund for Regional Development “ERDF/EU A way of making Europe”; and Worldwide Cancer Research grant: WWCR, 20-0144. Additional funding to CLR was from ICREA Acadèmia program (2014 and 2022 awards) of Institució Catalana de Recerca i Estudis Avançats (ICREA, Generalitat de Catalunya). VCP was funded by a predoctoral fellowship by the program “Formación de Profesorado Universitario” of the Spanish Ministry of Universities: FPU19-04119. STV was funded by a predoctoral fellowship of the Spanish Ministry of Economy and Competitiveness: BES-2013-062670. CTG was funded by a predoctoral fellowship of the Spanish Ministry of Science and Innovation: PRE2022-102056. Additional funding to CLR and JA laboratory was from the Departament de Recerca i Universitats, Generalitat de Catalunya 2021SGR00683; and the “Unidad de Excelencia María de Maeztu” program by the Agencia Estatal de Investigación-AEI (MICIU/AEI/10.13039/501100011033): CEX2018-000792-M, and CEX2024-001431-M. AC was funded by grant: PID2024-155263OB-I00 from Agencia Estatal de Investigación MICIU/AEI/ 10.13039/501100011033. MG was funded by Ramon y Cajal grant RYC2021-032169-I.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Poorly perfused tumor regions harbor T cells with a glucose-dependent effector phenotype

  • Riera-Borrull, Marta
  • Cerdán Porqueras, Víctor
  • Tejedor Vaquero, Sonia, 1988-
  • Tomaselli González, Claudia
  • Guzmán, Mauricio
  • Martinuzzi, Donata
  • Ceacero-Heras, Diego
  • Cerutti, Andrea, 1965-
  • Aramburu, José (Aramburu Beltrán)
  • López Rodríguez, M. Cristina
Data de publicació electrònica: 27-05-2026, Effector T lymphocytes are avid nutrient consumers, but can function in nutrient-poor tumor microenvironments. Availability of key nutrients such as glucose inside the tumor is not homogeneous, and how tumor-infiltrating T lymphocytes (TILs) differ between regions with better and poorer blood perfusion is not well known. Here we show that in vitro-stimulated TILs can induce substantial production of hallmark glucose-dependent cytokines under glucose concentrations 20 times lower than in blood. In vivo, effector TILs in tumor regions with poor access to blood show comparable capacity for inducing IFNγ and granzyme B to TILs with fuller accessibility; exhibit an enhanced type I IFN response supported by local myeloid cells; and unexpectedly, have reduced expression of immune checkpoint and Treg-associated markers. TILs with poor blood accessibility also have lower biosynthetic activity than highly blood-accessible TILs, yet both compartments depend fundamentally on glucose for ATP production. Thus, effector T lymphocytes in poorly perfused tumor regions can maintain specific glucose-dependent responses, and might be partially protected from inhibitory and exhausting pressure from the tumor microenvironment., We would like to thank Òscar Fornas, Nico Baeza, Alexandre Bote, Eva Julià, and Erica Ramírez of the Universitat Pompeu Fabra and Center for Genomic Regulation (UPF/CRG) Flow Cytometry Unit for excellent guidance with flow cytometry. We also thank Jochen Hecht, Irene Navarrete (CRG Genomics Unit) and the CRG Genomics Unit for advice with and performing the RNA-sequencing; and Julia Ponomarenko and Sarah Bonnin (CRG Bioinformatics Unit) for bioinformatics analysis of RNA-sequencing data. CLR and JA were funded by: grants RTI2018-095902-B-I00, PID2021-128721OB-I00, and PID2024-159862OB-I00, from Agencia Estatal de Investigación MICIU/AEI/ 10.13039/501100011033 and the European Fund for Regional Development “ERDF/EU A way of making Europe”; and Worldwide Cancer Research grant: WWCR, 20-0144. Additional funding to CLR was from ICREA Acadèmia program (2014 and 2022 awards) of Institució Catalana de Recerca i Estudis Avançats (ICREA, Generalitat de Catalunya). VCP was funded by a predoctoral fellowship by the program “Formación de Profesorado Universitario” of the Spanish Ministry of Universities: FPU19-04119. STV was funded by a predoctoral fellowship of the Spanish Ministry of Economy and Competitiveness: BES-2013-062670. CTG was funded by a predoctoral fellowship of the Spanish Ministry of Science and Innovation: PRE2022-102056. Additional funding to CLR and JA laboratory was from the Departament de Recerca i Universitats, Generalitat de Catalunya 2021SGR00683; and the “Unidad de Excelencia María de Maeztu” program by the Agencia Estatal de Investigación-AEI (MICIU/AEI/10.13039/501100011033): CEX2018-000792-M, and CEX2024-001431-M. AC was funded by grant: PID2024-155263OB-I00 from Agencia Estatal de Investigación MICIU/AEI/ 10.13039/501100011033. MG was funded by Ramon y Cajal grant RYC2021-032169-I.